Related Experiment Video
Updated: May 25, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees
Donna M Coviello1, James W Cornish, Kevin G Lynch
1University of Pennsylvania, Philadelphia, Pennsylvania, USA. coviello d@mail.trc.upenn.edu
Abstract:
A feasibility study was conducted to pilot test the ability of 5 sites to recruit, treat, and retain opioid-dependent offenders in a trial of extended-release injectable naltrexone (XR-NTX). The participants, 61 previously opioid-dependent individuals under legal supervision in the community, received up to 6 monthly injections of Depotrex brand naltrexone and completed a 6-month follow-up interview. Six-month outcomes showed that those who completed treatment had significantly fewer opioid-positive urines and were less likely to have been incarcerated than those who had not completed treatment. The findings indicate that XR-NTX holds promise as a feasible, effective treatment option for opioid-dependent offenders.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

